Volume 21, Number 12—December 2015
Synopsis
Opportunistic Pulmonary Bordetella hinzii Infection after Avian Exposure
Table
Antimicrobial drug susceptibility testing for human Bordetella hinzii isolates by the Etest method*
Antimicrobial drug | Case-patient 1† | Case-patient 2† | BC-306 (11) | BC-305 (11) | BL-3210 (3) | Hristov et al. isolate 1 (10)‡ | Hristov et al. isolate 2 (10)‡ | Hristov et al. isolate 3 (10)‡ |
---|---|---|---|---|---|---|---|---|
Amoxicillin | ND | 32 | 16§ | 16§ | 12§ | ND | ND | ND |
Amoxicillin/clavulanic acid | ND | ND | 32 | 16 | ND | ND | ND | ND |
Ampicillin/sulbactam | ND | ND | 16/8 | 16/8 | ND | ND | ND | ND |
Piperacillin | 0.38 | ND | ND | ND | ND | 32 | ND | ND |
Piperacillin/tazobactam | 0.25 | 0.75 | 1 | 1 | ND | ND | ND | ND |
Ticarcillin | ND | ND | ND | ND | ND | >32 | >64 | ND |
Ticarcillin/clavulanic acid | ND | 32 | 32 | 64 | ND | ND | ND | ND |
Cefoxitine | ND | >256 | ND | ND | ND | ND | ND | ND |
Cefotaxime | ND | >32 | ND | ND | >32 | ND | ND | ND |
Ceftriaxone | ND | ND | 64 | 64 | ND | ND | ND | >32 |
Ceftazidime | 1.5 | 2 | 4 | 4 | 4 | ND | ND | ND |
Cefepime | ND | 6 | 8 | 8 | ND | >16 | >16 | >16 |
Ertapenem | 3 | 0.023 | ND | ND | ND | ND | ND | ND |
Imipenem | 0.75 | 1.5 | 2 | 2 | 1 | ND | ND | ND |
Meropenem | 1 | 0.125 | ND | ND | ND | ≤1 | 8 | 4 |
Doripenem | 0.5 | 0.125 | ND | ND | ND | ND | ND | ND |
Aztreonam | ND | ND | ND | ND | ND | >16 | >16 | ND |
Gentamicin | 0.75 | 4 | 2 | 4 | 4 | ≤1 | 4 | ≤2 |
Tobramycin | 4 | 48 | ND | ND | ND | >8 | >8 | 4 |
Amikacin | 2 | 16 | ND | ND | ND | 16 | ≤4 | ≤8 |
Clarithromycin | 4 | ND | ND | ND | ND | ND | ND | ND |
Clindamycin | >256 | ND | ND | ND | ND | ND | ND | ND |
Rifampin | 1 | >32 | N | ND | ND | ND | ND | ND |
Levofloxacin | >32 | 0.25 | 2 | 2 | ND | ND | ND | ND |
Ciprofloxacin | >32 | 0.75 | 4 | 4 | >32 | >2 | >2 | >2 |
Moxifloxacin | 4 | 0.5 | ND | ND | ND | ND | ND | ND |
Cotrimoxazole | 0.38 | ND | 0.047 | 0.023 | ND | ≤0.5/9.5 | 2/38 | ND |
Vancomycin | >32 | >256 | ND | ND | ND | ND | ND | ND |
Teicoplanin | >32 | >256 | ND | ND | ND | ND | ND | ND |
Daptomycine | >256 | >256 | ND | ND | ND | ND | ND | ND |
Linezolid | >256 | >256 | ND | ND | ND | ND | ND | ND |
Fusidic acid | >32 | ND | ND | ND | ND | ND | ND | ND |
Tetracycline | ND | ND | ND | ND | 0.38 | ND | ND | ND |
Minocycline | 1 | ND | ND | ND | ND | ≤2 | >8 | ND |
Tigecycline | 0.5 | 0.38 | ND | ND | ND | ND | ND | ND |
Colistin | 0.38 | 0.094 | ND | ND | ND | ND | ND | ND |
Fosfomycine | >1024 | >1024 | ND | ND | ND | ND | ND | ND |
*Values are MICs as determined by Etest in μg/mL ND, not determined.
†This study.
‡Isolates 1, 2, and 3 of Hristov et al. case correspond to respiratory isolates (1 and 2) and blood isolate (isolate 3).
§Ampicillin rather than amoxicillin was tested.
References
- Register KB, Kunkle RA. Strain-specific virulence of Bordetella hinzii in poultry. Avian Dis. 2009;53:50–4. DOIPubMedGoogle Scholar
- Jiyipong T, Morand S, Jittapalapong S, Raoult D, Rolain JM. Bordetella hinzii in rodents, Southeast Asia. Emerg Infect Dis. 2013;19:502–3. DOIPubMedGoogle Scholar
- Arvand M, Feldhues R, Mieth M, Kraus T, Vandamme P. Chronic cholangitis caused by Bordetella hinzii in a liver transplant recipient. J Clin Microbiol. 2004;42:2335–7. DOIPubMedGoogle Scholar
- Cookson BT, Vandamme P, Carlson LC, Larson AM, Sheffield JV, Kersters K, Bacteremia caused by a novel Bordetella species, “B. hinzii. J Clin Microbiol. 1994;32:2569–71 .PubMedGoogle Scholar
- Funke G, Hess T, von Graevenitz A, Vandamme P. Characteristics of Bordetella hinzii strains isolated from a cystic fibrosis patient over a 3-year period. J Clin Microbiol. 1996;34:966–9 .PubMedGoogle Scholar
- Register KB, Sacco RE, Nordholm GE. Comparison of ribotyping and restriction enzyme analysis for inter- and intraspecies discrimination of Bordetella avium and Bordetella hinzii. J Clin Microbiol. 2003;41:1512–9. DOIPubMedGoogle Scholar
- Hayashimoto N, Morita H, Yasuda M, Ishida T, Kameda S. Takakura A, et al. Prevalence of Bordetella hinzii in mice in experimental facilities in Japan. Res Vet Sci. 2012;93:624–6.
- Vandamme P, Hommez J, Vancanneyt M, Monsieurs M, Hoste B. Cookson B, et al. Bordetella hinzii sp. nov., isolated from poultry and humans. Int J Syst Bacteriol. 1995;45:37–45.
- Fry NK, Duncan J, Edwards MT, Tilley RE, Chitnavis D, Harman R, A UK clinical isolate of Bordetella hinzii from a patient with myelodysplastic syndrome. J Med Microbiol. 2007;56:1700–3. DOIPubMedGoogle Scholar
- Hristov AC, Auwaerter PG, Romagnoli M, Carroll KC. Bordetella hinzii septicemia in association with Epstein-Barr virus viremia and an Epstein-Barr virus–associated diffuse large B-cell lymphoma. Diagn Microbiol Infect Dis. 2008;61:484–6. DOIPubMedGoogle Scholar
- Kattar MM, Chavez JF, Limaye AP, Rassoulian-Barrett SL, Yarfitz SL, Carlson LC, Application of 16S rRNA gene sequencing to identify Bordetella hinzii as the causative agent of fatal septicemia. J Clin Microbiol. 2000;38:789–94 .PubMedGoogle Scholar
- Spilker T, Liwienski AA. LiPuma JJ. Identification of Bordetella spp. in respiratory specimens from individuals with cystic fibrosis. Clin Microbiol Infect. 2008;14:504–6. DOIPubMedGoogle Scholar
- Gadea I, Cuenca-Estrella M, Benito N, Blanco A, Fernandez-Guerrero ML, Valero-Guillen PL, Bordetella hinzii, a “new” opportunistic pathogen to think about. J Infect. 2000;40:298–9. DOIPubMedGoogle Scholar
- Palacián Ruiz MP, Vasquez Martinez MA, Lopez Calleja AI. Respiratory infection caused by Bordetella hinzii. Arch Bronconeumol. 2013;49:409–10 .PubMedGoogle Scholar
- Degand N, Carbonnelle E, Dauphin B, Beretti JL, Le Bourgeois M, Sermet-Gaudelus I, Matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of nonfermenting gram-negative bacilli isolated from cystic fibrosis patients. J Clin Microbiol. 2008;46:3361–7. DOIPubMedGoogle Scholar
- Le Coustumier A, Njamkepo E, Cattoir V, Guillot S, Guiso N. Bordetella petrii infection with long-lasting persistence in human. Emerg Infect Dis. 2011;17:612–8. DOIPubMedGoogle Scholar
- Pritt B, O'Brien L, Winn W. Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol. 2007;128:32–4. DOIPubMedGoogle Scholar